------------------------------ OMB APPROVAL ------------------------------ OMB Number 3235-0362 Expires: February 1, 1994 Estimated average burden hours per response ....... 1.0 ------------------------------ U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 5 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 [ ] Check this box if no longer subject of Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). [ ] Form 3 Holdings Reported [ ] Form 4 Transaction Reported ================================================================================ 1. Name and Address of Reporting Person Johnson Alan G. -------------------------------------------------------------------------------- (Last) (First) (Middle) 2503 South Hanley Road -------------------------------------------------------------------------------- (Street) St. Louis MO 63144 -------------------------------------------------------------------------------- (City) (State) (Zip) ================================================================================ 2. Issuer Name and Ticker or Trading Symbol KV Pharmaceutical Company; KV.A/KV.B ================================================================================ 3. IRS or Social Security Number of Reporting Person (Voluntary) ================================================================================ 4. Statement for Month/Year March 31, 2000 ================================================================================ 5. If Amendment, Date of Original (Month/Year) ================================================================================ 6. Relationship of Reporting Person to Issuer (Check all applicable) [ X ] Director [ ] 10% Owner [ X ] Officer (give title below) [ ] Other (specify below) Senior Vice President/Secretary ================================================================================ 7. Individual or Joint/Group Reporting [ X ] Form Filed by One Reporting Person [ ] Form Filed by More Than One Reporting Person ================================================================================ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ================================================================================

FORM 5 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================

Explanation of Responses: (1) 10,000 shares initially and an additional 10,000 shares each year thereafter. (2) 3,000 shares currently exercisable, rest at the rate of an additional 1,500 shares November 6th of each year thereafter. /s/ Alan G. Johnson 5/15/00 --------------------------------------------- ----------------------- Signature of Reporting Person Date

KV PHARMACEUTICAL CO /DE/ 5